NEULASTA 6 mg/0.6ml sécurisée ser pré
7680563260047
CH-56326
L03AA13
06.07.3.
Reimbursement limitations:
NEULASTA
Administration au cours des chimiothérapies fortement myélotoxiques permettant d'espérer une évolution positive chez les patients …
1 / 2
google
Details
- Product number
- 5632601
- CPT
- -
- Packaging group
- 1
- Unit
- Spritze(n)
- Composition
- pegfilgrastimum 6 mg, acidum aceticum glaciale, natrii hydroxidum corresp. natrium 20.4 µg, sorbitolum 30 mg, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.6 ml.
Articles (1)
Neulasta, Injektionslösung in einer Fertigspritze
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
6.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
20.4 UG | Substance | HBESI |
|
(N/A)
|
30.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1287.20
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2003
Authorization holder
Amgen Switzerland AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 56326
- Drug name
- Neulasta, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- L03AA13
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 01/09/2003
- Authorization expiration date
- 31/12/9999
- IT number
- 06.07.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- NEULASTA 6 mg/0.6ml sécurisée ser pré
- Description (DE)
- NEULASTA 6 mg/0.6ml m Nadelschutz Fertspr
- Market launch
- 01/09/2003
- Narcotic (BTM)
- No